Int. J. Life. Sci. Scienti. Res., 2(4): 466-471
(ISSN: 2455-1716)
Impact Factor 2.4
JULY-2016
Research Article (Open access)
Evaluation of CRP as a Preindicative Marker in Women with Preterm Labour and Preterm Prelabour Rupture of Membrane (PPROM) Dr. Sujata Deo1, Dr. S.P Jaiswar1, Dr. P.L. Sankhwar1, Pratibha Kumari1, Dr. Sunita Singh2* 1
*
Department of Obstetrics and Gynaecology, King George Medical University, U.P, India 2 Department of Microbiology, King George Medical University, U.P, India
Address for Correspondence: Dr. Sunita Singh, Research Officer, Department Microbiology, King George Medical University, U.P, India Received: 17 May 2016/Revised: 7 June 2016/Accepted: 29 June 2016
ABSTRACT- Introduction: Early detection of infection is most important during the conservative management of patients with PROM and preterm labour. Hence CRP is suitable markers for predicting risk of preterm delivery. Objective: To determine the diagnostic accuracy of C-reactive protein in the detection of chorioamnionitis in women with Preterm labor and PPROM and to test sensitivity/specificity/positive predictive valve of CRP in diagnosing chorioamnionitis against gold standard of histopathological examination of placenta. Study design: Prospective case-control study. Method: A study conducted on total 240 antenatal women, 120 cases of PROM and 120 cases of normal term pregnancy were used as a control. A detailed obstetrical and menstrual history was recorded along with systemic and local examination. Subjects were evaluated prospectively and managed expectantly with use of tocolytics, antibiotics and Steroids. Frequent vital signs monitoring and hematological investigation were done. CRP levels were determined by qualitatively. After delivery placenta was sent for histopathological examination for the presence of chorioamnionitis. Result: CRP emerged as an early and sensitive predictor of chorioamnionitis in diagnosing histopathological chorioamnionitis.CRP had sensitivity and specificity of 100% and 50% respectively .the positive predictive value was 29.27% and negative predictive value 100% whereas TLC has sensitivity only 37.93%. Conclusion: CRP is early and reliable indicator of histopathological and clinical chorioamnionitis in comparison of leucocyte counts and clinical parameter. Thus CRP can prove useful markers in identify early and subclinical infection which could lead to preterm labour and premature rupture of membrane. Key-words- Preterm birth, C-reactive protein, PPROM, Chorioamnionitis -------------------------------------------------IJLSSR----------------------------------------------INTRODUCTION The management of patients with preterm labour and premature rupture of membrane poses one of the most serious dilemmas in obstetrics since they significantly increase the likelihood of prematurity and serious perinatal infection. Potential pathogens largely arise from the ascending route and the endogenous vaginal flora, and may cause chorioamnionitis (1). Access this article online Quick Response Code: Website: www.ijlssr.com
DOI: 10.21276/ijlssr.2016.2.4.24
Preterm birth rates have been reported to range from 5% to 7% of live births in some developed countries, but are estimated to be substantially higher in developing countries (2) . Etiology of preterm birth is thought to be multifactorial. It is, however, unclear whether preterm birth results from the interaction of several pathways or the independent effect of each pathway. Causal factors linked to preterm birth include medical conditions of the mother or fetus, genetic influences, environmental exposure, infertility treatments, behavioural and socioeconomic factors and iatrogenic prematurity (3). The choice between immediate active or expectant management for women with PROM from 34 to 37 weeks of gestation remains controversial (4) and may require active management, mainly because of the risk of neonatal infection (5). By gestational age, 5% of preterm births occur at less than
Copyright Š 2015-2016| IJLSSR by Society for Scientific Research is under a CC BY-NC 4.0 International License
Page 466